Ino, H., Nakazawa, E., & Akabayashi, A. (2021). Drug Repurposing for COVID-19: Ethical Considerations and Roadmaps. Cambridge quarterly of healthcare ethics, 30(1), 51-58. doi:10.1017/S0963180120000481
Chicago-Zitierstil (17. Ausg.)Ino, Hiroyasu, Eisuke Nakazawa, und Akira Akabayashi. "Drug Repurposing for COVID-19: Ethical Considerations and Roadmaps." Cambridge Quarterly of Healthcare Ethics 30, no. 1 (2021): 51-58, https://doi.org/10.1017/S0963180120000481.
MLA-Zitierstil (8. Ausg.)Ino, Hiroyasu, et al. "Drug Repurposing for COVID-19: Ethical Considerations and Roadmaps." Cambridge Quarterly of Healthcare Ethics, vol. 30, no. 1, 2021, pp. 51-58, https://doi.org/10.1017/S0963180120000481.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.